0001213900-22-022648.txt : 20220429 0001213900-22-022648.hdr.sgml : 20220429 20220429142314 ACCESSION NUMBER: 0001213900-22-022648 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220429 FILED AS OF DATE: 20220429 DATE AS OF CHANGE: 20220429 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Meihua International Medical Technologies Co., Ltd. CENTRAL INDEX KEY: 0001835615 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-41291 FILM NUMBER: 22873763 BUSINESS ADDRESS: STREET 1: 88 TONGDA ROAD STREET 2: TOUQIAO TOWN, GUANGLING DISTRICT CITY: YANGZHOU STATE: F4 ZIP: 225000 BUSINESS PHONE: 646-861-7891 MAIL ADDRESS: STREET 1: C/0 500 FIFTH AVE. STREET 2: SUITE 938 CITY: NEW YORK STATE: NY ZIP: 10110 6-K 1 ea159133-6k_meihuaintern.htm REPORT OF FOREIGN PRIVATE ISSUER

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 OF THE

SECURITIES EXCHANGE ACT OF 1934

 

For the month of April 2022

 

Commission File Number 001-41291

 

Meihua International Medical Technologies Co., Ltd.

(Translation of registrant’s name into English)

 

88 Tongda Road, Touqiao Town

Guangling District, Yangzhou, 225000

People’s Republic of China

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F: Form 20-F ☒ Form 40-F ☐

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐

 

Note: Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐

 

Note: Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant’s “home country”), or under the rules of the home country exchange on which the registrant’s securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant’s security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.

 

 

 

 

 

  

Effective April 26, 2022, Tongying Zhang resigned her position as our Chief Financial Officer. Pending the selection and appointment of a new CFO, our CEO, Yulin Wang, will serve as interim Chief Financial Officer.

 

1

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Date: April 29, 2022 Meihua International Medical Technologies Co., Ltd.
     
  By: /s/ Yulin Wang
  Yulin Wang
Chief Executive Officer

 

2